Toronto, Ontario – May 17, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking fitness scan vertical tailored specifically for athletes, teams, and sports federations. Leveraging state-of-the-art AI technology, Predictmedix’s fitness scan vertical delivers a comprehensive analysis of an athlete’s fitness level, empowering them to optimize their training and elevate their performance.
The innovative fitness scan vertical by Predictmedix harnesses advanced machine learning algorithms to provide athletes with precise and personalized insights into their physical capabilities. By evaluating key performance factors such as strength, endurance, flexibility, and cardiovascular health, the platform offers athletes a holistic understanding of their fitness profile. This invaluable information enables athletes to identify areas for improvement and craft customized training programs tailored to their unique needs and aspirations.
Market research indicates a significant growth opportunity for Predictmedix’s new fitness scan vertical. The Global Health and Fitness Club Market is projected to reach USD 169,696.72 Million by 2030, exhibiting a remarkable compound annual growth rate (CAGR) of 7.67% from 2023 to 2030.1 With its expertise in AI-driven health technologies and in response to market demand, Predictmedix is poised to revolutionize fitness assessment and optimization.
“We are delighted to introduce our cutting-edge fitness scan vertical, aimed at empowering athletes and sports teams to unleash their full potential,” commented Dr. Rahul Kushwah, COO of Predictmedix. “By providing a comprehensive analysis of an athlete’s fitness level, we equip them with the tools to unlock their strengths, address areas for growth, and achieve their performance goals. Our vision is to bring seamless AI tools to the sports industry to maximize performance and ROI.”
Beyond individual athletes, Predictmedix’s fitness scan vertical caters to sports teams and federations, offering a powerful tool for talent identification, injury prevention, and performance optimization. By analyzing data from multiple athletes, the platform uncovers trends and patterns that assist coaches and trainers in making informed decisions about training methodologies and developmental strategies.
Dr. Kushwah further highlighted, “Through our meaningful discussions with notable figures and key players in the sports industry, we have observed a remarkable level of interest in our fitness scan vertical. The industry recognizes the value and potential our solution holds. By leveraging AI and machine learning, we provide athletes and sports organizations with highly accurate and actionable insights. This empowers them to enhance their capabilities, improve performance, and strive for greater success.”
Predictmedix continues to spearhead innovation in the healthcare industry with its revolutionary AI-powered solutions. The launch of the fitness scan vertical exemplifies the company’s unwavering commitment to advancing athletic performance through cutting-edge technology.
About Predictmedix Inc.
Predictmedix (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations – powered by a proprietary artificial intelligence (AI) – use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue or various mental illnesses. Predictmedix’s proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.
Public Relations Contact
For further media information or to set up an interview, please contact:
Hudes Communications International
(905) 660 9155
Dr. Rahul Kushwah
(647) 889 6916
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any Page 4 of 4 future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company’s shares, including price volatility due to events that may or may not be within such party’s control; reliance on management; and the emergency of additional competitors in the industry.
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
Disclaimer: “The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.”
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.